Trial Profile
The phase III study to investigate the effect of C-16G2 in patient with dental caries.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 15 Jul 2015
Price :
$35
*
At a glance
- Drugs C 16G2 (Primary)
- Indications Dental caries
- Focus Therapeutic Use
- Sponsors C3J Therapeutics
- 15 Jul 2015 New trial record
- 13 Jul 2015 According to C3 Jian media release, the company is planning to initiate phase 3 trial.